Visual disorders, particularly myopia, have become a significant public health concern among adolescents globally, with prevalence rates soaring in recent ...

Yuvezzi, a combination cholinergic agonist and alpha-adrenergic agonist, is now FDA-approved as a once-daily treatment for ...

The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics. Yuvezzi ...

The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive alternative to glasses or surgery. Phase 3 trials demonstrated superior ...

In children born very preterm, suboptimal visual acuity (VA) at 5.5 years of age was associated with lower cognitive and motor performance, along with increased behavioural difficulties. Researchers ...

This study from MIT explores eye evolution through AI simulations, uncovering how different tasks shape visual systems and their neural processing requirements.

Acuity Brands is down 15.4% since the beginning of the year, and at $315.85 per share, it is trading 16.2% below its 52-week high of $376.69 from January 2026. Investors who bought $1,000 worth of ...

Dr. Jeff Goldberg explains visual acuity. Deputy AG Todd Blanche could face sanctions ‘A successful night': Kennedy Center pushes back on historic low ‘Honors' ratings Rob Gronkowski reveals he’s ...

There were 26 serious adverse events in 19 participants; 21 (81%) occurred within 2 months after surgery. HealthDay News — In participants with geographic atrophy due to age-related macular ...

LONDON--(BUSINESS WIRE)--Acuity Knowledge Partners (Acuity), a leading global provider of bespoke research, data management, analytics and AI solutions to the financial services sector, has announced ...

I discussed this issue with Anna Ostropolets at the Vocabulary office hours on 9/4/2025. The Eye Care and Vision Research Workgroup has finally reached consensus on how to ETL a Best Recorded Visual ...